Candel Therapeutics Inc (CADL)
EBITDA Growth
-760.56%
Quarterly · Period ending:
CADL EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-760.56%period ending
Latest reported-760.56%period ending
CADL Quarterly EBITDA YoY % (-102.58% → -760.56%)
Year-over-year change
High-resolution chart · PNG
CADL ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -760.5604% | |
| -190.1387% | |
| -107.7467% | |
| -10.0767% | |
| 79.8422% | |
| 208.2742% | |
| -32.0948% | |
| -31.8176% | |
| -145.2599% | |
| 7.9437% | |
| -29.099% | |
| 5.5625% | |
| -147.6325% | |
| 9.8061% | |
| -4.2052% | |
| 50.6598% | |
| 33.3774% | |
| -90.4772% | |
| -23.5823% | |
| -496.9305% | |
| -102.7576% | |
| -102.5809% |